Aim Immunotech Stock Technical Analysis
| AIM Stock | USD 1.21 0.01 0.83% |
As of the 27th of January, AIM ImmunoTech shows the Coefficient Of Variation of (650.08), mean deviation of 4.42, and Risk Adjusted Performance of (0.10). AIM ImmunoTech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm AIM ImmunoTech standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if AIM ImmunoTech is priced adequately, providing market reflects its regular price of 1.21 per share. Given that AIM ImmunoTech is a hitting penny stock territory we recommend to closely look at its jensen alpha.
AIM ImmunoTech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as AIM, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AIMAIM ImmunoTech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AIM ImmunoTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AIM ImmunoTech is measured differently than its book value, which is the value of AIM that is recorded on the company's balance sheet. Investors also form their own opinion of AIM ImmunoTech's value that differs from its market value or its book value, called intrinsic value, which is AIM ImmunoTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AIM ImmunoTech's market value can be influenced by many factors that don't directly affect AIM ImmunoTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AIM ImmunoTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM ImmunoTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AIM ImmunoTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AIM ImmunoTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AIM ImmunoTech.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in AIM ImmunoTech on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding AIM ImmunoTech or generate 0.0% return on investment in AIM ImmunoTech over 90 days. AIM ImmunoTech is related to or competes with Kala Pharmaceuticals, Oragenics, Pasithea Therapeutics, Vyne Therapeutics, Quoin Pharmaceuticals, Ensysce Biosciences, and XTL Biopharmaceutica. AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple... More
AIM ImmunoTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AIM ImmunoTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AIM ImmunoTech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 29.72 | |||
| Value At Risk | (10.32) | |||
| Potential Upside | 7.69 |
AIM ImmunoTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AIM ImmunoTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AIM ImmunoTech's standard deviation. In reality, there are many statistical measures that can use AIM ImmunoTech historical prices to predict the future AIM ImmunoTech's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (1.15) | |||
| Total Risk Alpha | (1.50) | |||
| Treynor Ratio | (0.30) |
AIM ImmunoTech January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (0.29) | |||
| Mean Deviation | 4.42 | |||
| Coefficient Of Variation | (650.08) | |||
| Standard Deviation | 6.0 | |||
| Variance | 36.0 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.15) | |||
| Total Risk Alpha | (1.50) | |||
| Treynor Ratio | (0.30) | |||
| Maximum Drawdown | 29.72 | |||
| Value At Risk | (10.32) | |||
| Potential Upside | 7.69 | |||
| Skewness | 0.0247 | |||
| Kurtosis | 2.07 |
AIM ImmunoTech Backtested Returns
AIM ImmunoTech secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15 % return per unit of return volatility over the last 3 months. AIM ImmunoTech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AIM ImmunoTech's Risk Adjusted Performance of (0.10), mean deviation of 4.42, and Coefficient Of Variation of (650.08) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.16, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AIM ImmunoTech will likely underperform. At this point, AIM ImmunoTech has a negative expected return of -0.92%. Please make sure to confirm AIM ImmunoTech's day median price, relative strength index, as well as the relationship between the kurtosis and maximum drawdown , to decide if AIM ImmunoTech performance from the past will be repeated in the future.
Auto-correlation | 0.49 |
Average predictability
AIM ImmunoTech has average predictability. Overlapping area represents the amount of predictability between AIM ImmunoTech time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AIM ImmunoTech price movement. The serial correlation of 0.49 indicates that about 49.0% of current AIM ImmunoTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.49 | |
| Spearman Rank Test | 0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
AIM ImmunoTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
AIM ImmunoTech Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of AIM ImmunoTech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About AIM ImmunoTech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of AIM ImmunoTech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of AIM ImmunoTech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on AIM ImmunoTech price pattern first instead of the macroeconomic environment surrounding AIM ImmunoTech. By analyzing AIM ImmunoTech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of AIM ImmunoTech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to AIM ImmunoTech specific price patterns or momentum indicators. Please read more on our technical analysis page.
AIM ImmunoTech January 27, 2026 Technical Indicators
Most technical analysis of AIM help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for AIM from various momentum indicators to cycle indicators. When you analyze AIM charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (0.29) | |||
| Mean Deviation | 4.42 | |||
| Coefficient Of Variation | (650.08) | |||
| Standard Deviation | 6.0 | |||
| Variance | 36.0 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.15) | |||
| Total Risk Alpha | (1.50) | |||
| Treynor Ratio | (0.30) | |||
| Maximum Drawdown | 29.72 | |||
| Value At Risk | (10.32) | |||
| Potential Upside | 7.69 | |||
| Skewness | 0.0247 | |||
| Kurtosis | 2.07 |
AIM ImmunoTech January 27, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as AIM stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,940 | ||
| Daily Balance Of Power | 0.17 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 1.21 | ||
| Day Typical Price | 1.21 | ||
| Price Action Indicator | 0.01 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AIM ImmunoTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AIM ImmunoTech is measured differently than its book value, which is the value of AIM that is recorded on the company's balance sheet. Investors also form their own opinion of AIM ImmunoTech's value that differs from its market value or its book value, called intrinsic value, which is AIM ImmunoTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AIM ImmunoTech's market value can be influenced by many factors that don't directly affect AIM ImmunoTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AIM ImmunoTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM ImmunoTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.